Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

A new look at the statistical model identification

Hirotugu Akaike · IEEE Transactions on Automatic Control · 1974 · 50.7K citations · Full text

Business, Biostatistics, Statistical Modeling +9

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

Stuart Pocock, Richard Simon · Biometrics · 1975 · 2.4K citations

Public Health, Biostatistics, Clinical Epidemiology +12

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

Anthony Howell, Jack Cuzick, M Baum et al. · The Lancet · 2005 · 2.3K citations

Medicine, Oncology, Breast Oncology +6

Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures

Ethel S. Siris, Ya-Ting Chen, Thomas A. Abbott et al. · Archives of Internal Medicine · 2004 · 1.1K citations

Medicine, Preventive Medicine, Bone Metabolism +16

Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.

Lee S. Rosen, David Gordon, Mary Kaminski et al. · PubMed · 2002 · 899 citations

Medicine, Pharmacology, Pharmacotherapy +17